1921
The Global Pandemic of Falsified Medicines: Laboratory and Field Innovations and Policy Implications
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
Preview this article:
Zoom in
Zoomout

The Global Pandemic of Falsified Medicines: Laboratory and Field Innovations and Policy Perspectives, Page 1 of 1

| /docserver/preview/fulltext/14761645/92/6_Suppl/2-1.gif

There is no abstract available for this article.
Use the preview function to the left.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.15-0221
2015-06-03
2017-09-19
Loading full text...

Full text loading...

/deliver/fulltext/14761645/92/6_Suppl/2.html?itemId=/content/journals/10.4269/ajtmh.15-0221&mimeType=html&fmt=ahah

References

  1. World Health Organization, 2014. World Malaria Report 2014. Available at: http://www.who.int/malaria/publications/world_malaria_report_2014/report/en/. Accessed March 15, 2015.
  2. World Health Organization, 2014. Global Tuberculosis Report 2014. Available at: http://www.who.int/tb/publications/global_report/gtbr14_main_text.pdf. Accessed March 14, 2015.
  3. Joint United Nations Programme on HIV/AIDS, 2014. 2014 Progress Report on the Global Plan towards the Elimination of New HIV Infections among Children by 2015 and Keeping Their Mothers Alive. Available at: http://www.unaidsrstesa.org/sites/default/files/jc2681_2014-global-plan-progress_en.pdf. Accessed March 15, 2015.
  4. Hamburg M, Herrington JE, Nayyar GML, Breman JG, , 2015. Foreword to the global pandemic of falsified medicines: laboratory and field innovations and policy implications. , eds. The global pandemic of falsified medicines: laboratory and field innovations policies and perspectives. Am J Trop Med Hyg 92 (Suppl 6): 1.[Crossref]
  5. Tabernero P, Fernandez FM, Green M, Guerin P, Newton PN, , 2014. Mind the Gaps—the Epidemiology of Poor-Quality Anti-Malarials in the Malarious World—Analysis of the Worldwide Antimalarial Resistance Network Database. Mal J 13: 139. Available at: http://www.malariajournal.com/content/13/1/139. Accessed March 15, 2015.[Crossref]
  6. O'Conner A, , 2015. New York Attorney General targets supplements at major retailers. New York Times. Available at: http://well.blogs.nytimes.com/2015/02/03/new-york-attorney-general-targets-supplements-at-major-retailers/. Accessed March 15, 2015.
  7. World Health Organization, 2015. Essential Medicines—General information on Counterfeit Medicines. Available at: http://www.who.int/medicines/services/counterfeit/overview/en/. Accessed March 15, 2015.
  8. Blackstone EA, Fuhr JP, Jr Pociask S, , 2014. The health and economic effects of counterfeit drugs. Am Health Drug Benefits 7: 216224.
  9. Nayyar GML, Breman JG, Newton PN, Herrington J, , 2012. Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infect Dis 12: 488496.[Crossref]
  10. World Health Organization, 2010. Preliminary Draft Survey on National Legislation on “Counterfeit Medicines”: Feedback from Member States to the Circular Letter CL 25.2009. Available at: http://www.who.int/medicines/services/counterfeit/WHO_ACM_Report.pdf. Accessed March 15, 2015.
  11. Amin AA, Bird C, Passmore P, Dukes G, Tomson G, Simons B, Bate R, Philippe GJ, White NJ, Newton PN, , 2011. The primacy of public health considerations in defining poor quality medicines. PLoS Med 8: e1001139. Available at: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001139. Accessed March 15, 2015.[Crossref]
  12. Renschler JP, Walters K, Newton P, Laxminarayan P, Herrington JE, Nayyar GML, Breman JG, , 2015. Estimating under-five deaths associated with poor quality antimalarials in sub-Saharan Africa. , eds. The global pandemic of falsified medicines: laboratory and field innovations policies and perspectives. Am J Trop Med Hyg 92 (Suppl 6): 119126.[Crossref]
  13. Institute of Medicine, 2013. Countering the Problem of Falsified and Substandard Drugs. Washington, DC: The National Academies Press. Available at: https://www.iom.edu/Reports/2013/Countering-the-Problem-of-Falsified-and-Substandard-Drugs.aspx. Accessed March 15, 2015.
  14. Kovacs S, Hawes SE, Maley SN, Mosites E, Wong L, Stergachis A, , 2014. Technologies for detecting falsified and substandard drugs in low and middle-income countries. PLoS One 9: e90601. Available at: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0090601. Accessed March 15, 2015.
  15. Weaver AA, Lieberman M, Herrington JE, Nayyar GML, Breman JG, , 2015. Paper-based test cards for field detection of falsified and very low quality (VLQ) anti-infective and anti-malarial medications. , eds. The global pandemic of falsified medicines: laboratory and field innovations policies and perspectives. Am J Trop Med Hyg 92 (Suppl 6): 1723.[Crossref]
  16. Green MD, Hostetler DM, Nettey H, Ranieri N, Swamidoss I, Fernandez F, Newton P, Cinnamond M, Herrington JE, Nayyar GML, Breman JG, , 2015. Integration of novel low-cost colorometric and visual fluorescent techniques for rapid identification of counterfeit artemether-lumefantrine and other drugs in resource poor areas. , eds. The global pandemic of falsified medicines: laboratory and field innovations policies and perspectives. Am J Trop Med Hyg 92 (Suppl 6): 816.[Crossref]
  17. Ho NT, Desai D, Zaman MH, Herrington JE, Nayyar GML, Breman JG, , 2015. Rapid, sensitive and specific drug quality testing assay for antimalarials using luminescent reaction and novel microfluidic technology. , eds. The global pandemic of falsified medicines: laboratory and field innovations policies and perspectives. Am J Trop Med Hyg 92 (Suppl 6): 2430.[Crossref]
  18. Kaur H, Seifert K, Hawkes G, Coumbarides G, Alvar J, Croft SL, Herrington JE, Nayyar GML, Breman JG, , 2015. Chemical and bioassay techniques to authenticate quality of the antileishmanial drug miltefosine. , eds. The global pandemic of falsified medicines: laboratory and field innovations policies and perspectives. Am J Trop Med Hyg 92 (Suppl 6): 3138.[Crossref]
  19. Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M, the WHO Leishmaniasis Control Team, , 2012. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7: e35671. Available at: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0035671. Accessed March 15, 2015.[Crossref]
  20. World Health Organization, 2014. Report of the Third Meeting of the Member State Mechanism on Substandard/Spurious/Falsely Labelled Falsified/Counterfeit Medical Products. Available at: http://apps.who.int/gb/ssffc/pdf_files/MSM3/A_MSM3_3-en.pdf. Accessed March 15, 2015.
  21. United States Pharmacopeial Convention, 2015. Medicines Quality Database (MQDB). Available at: http://www.usp.org/global-health-programs/promoting-quality-medicines-pqmusaid/medicines-quality-database-mqdb. Accessed March 15, 2015.
  22. Yeung S, Lawford HLS, Tabernero P, Nguon C, van Wyk A, Malik N, DeSousa M, Rada O, Boravann M, Dwivedi P, Hostetler DM, Swamidoss I, Green MD, Fernandez FM, Kaur H, Herrington JE, Nayyar GML, Breman JG, , 2015. Quality of antimalarials at the epicenter of antimalarial drug resistance: results from an overt and mystery client survey in Cambodia. , eds. The global pandemic of falsified medicines: laboratory and field innovations policies and perspectives. Am J Trop Med Hyg 92 (Suppl 6): 3950.[Crossref]
  23. Lalani M, Kaur H, Mohammed N, Amanzai O, Mailk N, van Wyk A, Rashid H, Jan S, Kakar RM, Mojadidi MK, Leslie T, Herrington JE, Nayyar GML, Breman JG, , 2015. Substandard antimalarials available in Afghanistan: a case for assessing the quality of drugs in resource poor settings. , eds. The global pandemic of falsified medicines: laboratory and field innovations policies and perspectives. Am J Trop Med Hyg 92 (Suppl 6): 5158.[Crossref]
  24. ACT Consortium Drug Quality Project Team and the IMPACT2 Study Team Herrington JE, Nayyar GML, Breman JG, , 2015. Quality of artemisinin containing antimalarials in Tanzania's private sector—results from a nationally representative outlet survey. , eds. The global pandemic of falsified medicines: laboratory and field innovations policies and perspectives. Am J Trop Med Hyg 92 (Suppl 6): 7586.
  25. Hajjou M, Krech L, Lane-Barrow C, Roth L, Pribluda V, Phanouvong S, El Hadri L, Evans L, Raymond C, Yuan E, Lang S, Voung T-A, Okafor R, Chibew K, Lukulay P, Herrington JE, Nayyar GML, Breman JG, , 2015. Monitoring the quality of medicines: results from Africa, southeast Asia, and Latin America. , eds. The global pandemic of falsified medicines: laboratory and field innovations policies and perspectives. Am J Trop Med Hyg 92 (Suppl 6): 6874.[Crossref]
  26. Tabernero P, Mayxay M, Culzoni MJ, Dwivedi P, Swamidoss I, Allan EL, Khanthavong M, Phonlavong C, Vilayhong C, Yeuchaixiong S, Sichanh C, Sengaloundeth S, Kaur H, Fernandez FM, Green MD, Newton P, Herrington JE, Nayyar GML, Breman JG, , 2015. A repeat random survey of the prevalence of falsified and substandard antimalarials in the Lao PDR—a change for the better. , eds. The global pandemic of falsified medicines: laboratory and field innovations policies and perspectives. Am J Trop Med Hyg 92 (Suppl 6): 95104.[Crossref]
  27. Fadeyi I, Lalani M, Mailk N, van Wyk A, Kaur H, Herrington JE, Nayyar GML, Breman JG, , 2015. Quality of the antibiotics—amoxicillin and cotrimoxazole from Ghana, Nigeria, and the United Kingdom. , eds. The global pandemic of falsified medicines: laboratory and field innovations policies and perspectives. Am J Trop Med Hyg 92 (Suppl 6): 8794.[Crossref]
  28. Yong YL, Plançon A, Lau YH, Hostetler D, Fernandez F, Green M, Sounvoravong S, Nara S, Boravann M, Dumrong T, Bangsawan N, Tuc VV, Low MY, Lim CC, Lee R, Ai C, Newton P, Herrington JE, Nayyar GML, Breman JG, , 2015. Collaborative health and enforcement operations on the quality of antimalarials and antibiotics in SE Asia. , eds. The global pandemic of falsified medicines: laboratory and field innovations policies and perspectives. Am J Trop Med Hyg 92 (Suppl 6): 105112.[Crossref]
  29. Worldwide Antimalarial Resistance Network, 2015. Antimalarial Quality Surveyor. Available at: http://www.wwarn.org/resistance/surveyors/antimalarial-quality. Accessed March 15, 2015.
  30. Kaiser Health News, 2009. WHO Launches Counterfeit Drug Reporting System in Western Pacific Region. Available at: http://kaiserhealthnews.org/morning-breakout/dr00029898/. Accessed March 15, 2015.
  31. Mackey TM, Liang BA, York P, Kubic T, Herrington JE, Nayyar GML, Breman JG, , 2105. Empirical analysis of counterfeit drug penetration in global legitimate supply chains: a descriptive assessment. , eds. The global pandemic of falsified medicines: laboratory and field innovations policies and perspectives. Am J Trop Med Hyg 92 (Suppl 6): 5967.
  32. Nayyar GML, Attaran A, Clark JP, Culzoni M, Fernandez F, Herrington JE, Kendall M, Newton P, Breman JG, Herrington JE, Nayyar GML, Breman JG, , 2015. Responding to the pandemic of falsified medicines. , eds. The global pandemic of falsified medicines: laboratory and field innovations policies and perspectives. Am J Trop Med Hyg 92 (Suppl 6): 113118.[Crossref]
  33. Attaran A, Herrington JE, Nayyar GML, Breman JG, , 2015. Stopping murder by medicine: introducing the model law against medicine crime. , eds. The global pandemic of falsified medicines: laboratory and field innovations policies and perspectives. Am J Trop Med Hyg 92 (Suppl 6): 127132.[Crossref]
  34. Callard C, , 2010. Follow the money: how the billions of dollars that flow from smokers in poor nations to companies in rich nations greatly exceed funding for global tobacco control and what might be done about it. Tob Control 19: 285. Available at: http://tobaccocontrol.bmj.com/content/19/4/285/T1.expansion.html. Accessed March 15, 2015.[Crossref]
  35. Cinnamond M, Woods T, Herrington JE, Nayyar GML, Breman JG, , 2015. The Joint Inter-Agency Task Force and the Global Steering Committee for the Quality Assurance of Health Products: two new and proactive approaches to promoting access to safe and effective medicines. , eds. The global pandemic of falsified medicines: laboratory and field innovations policies and perspectives. Am J Trop Med Hyg 92 (Suppl 6): 133136.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.15-0221
Loading
/content/journals/10.4269/ajtmh.15-0221
Loading

Data & Media loading...

  • Received : 20 Mar 2015
  • Accepted : 10 Apr 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error